CAV1 and non-small cell lung carcinoma: CAV1 and cavin-1 themselves are unlikely to be suitable molecular targets for NSCLC treatment due to their crucial physiological functions in various organs even at low-expression levels17, 34, 35, 36, 37, 38, 39, 40.